Jane Street Group LLC lowered its stake in The Beauty Health Company (NASDAQ:SKIN – Free Report) by 74.1% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 80,832 shares of the company’s stock after selling 231,839 shares during the period. Jane Street Group LLC’s holdings in Beauty Health were worth $116,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also bought and sold shares of the company. SG Americas Securities LLC acquired a new stake in Beauty Health during the third quarter worth about $37,000. Sanctuary Advisors LLC acquired a new stake in shares of Beauty Health during the 2nd quarter worth approximately $47,000. Susquehanna Fundamental Investments LLC bought a new position in Beauty Health in the second quarter valued at approximately $105,000. HighTower Advisors LLC acquired a new position in Beauty Health during the third quarter valued at approximately $121,000. Finally, Atom Investors LP lifted its stake in Beauty Health by 19.7% during the third quarter. Atom Investors LP now owns 99,924 shares of the company’s stock worth $144,000 after purchasing an additional 16,416 shares during the last quarter. Institutional investors and hedge funds own 93.26% of the company’s stock.
Wall Street Analysts Forecast Growth
Separately, Canaccord Genuity Group boosted their price target on Beauty Health from $1.25 to $1.75 and gave the stock a “hold” rating in a report on Wednesday, November 13th. One research analyst has rated the stock with a sell rating, three have given a hold rating and one has given a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $2.55.
Beauty Health Price Performance
Shares of NASDAQ:SKIN opened at $1.52 on Wednesday. The firm has a 50 day simple moving average of $1.57 and a 200 day simple moving average of $1.61. The company has a market cap of $188.67 million, a price-to-earnings ratio of -3.62 and a beta of 0.81. The Beauty Health Company has a one year low of $0.91 and a one year high of $5.17. The company has a debt-to-equity ratio of 9.23, a current ratio of 6.56 and a quick ratio of 5.57.
Beauty Health Company Profile
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.
Further Reading
- Five stocks we like better than Beauty Health
- Most active stocks: Dollar volume vs share volume
- The Fed Is More Likely to Hike Than Cut Rates in 2025
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Investors Navigate Uncertainty by Seeking Refuge in Gold and Oil
- Canadian Penny Stocks: Can They Make You Rich?
- Archer Aviation Shares Slide, Now Bargain Priced for 2025
Want to see what other hedge funds are holding SKIN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Beauty Health Company (NASDAQ:SKIN – Free Report).
Receive News & Ratings for Beauty Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beauty Health and related companies with MarketBeat.com's FREE daily email newsletter.